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ABSTRACT. Ossification of the posterior longitudinal ligaments 
(OPLL) has been considered to be associated with abnormalities of bone 
metabolism, and transforming growth factor-β1 (TGF-β1) has been 
demonstrated to affect the bone remodeling process. We investigated 
two SNPs of the TGF-β1 promoter (-509C>T; rs1800469) and exon 
1 (869T>C; rs1982073) in 298 Koreans (98 patients with OPLL and 
200 control subjects). The promoter SNP -509C>T was determined by 
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PCR and RFLP, and the TaqMan probe assay was used to determine 
869T>C polymorphism genotypes. The subjects were divided into 
OPLL continuous group (continuous type plus mixed type) and OPLL 
segmental group (segmental and localized type). We also separately 
analyzed this association according to gender difference. There was 
no significant difference in genotype distributions of -509C>T and 
869T>C polymorphisms of the TGF-β1 gene between OPLL patients 
and controls. A combined analysis of TGF-β1 -509C>T and 869T>C 
polymorphisms showed no significant association with OPLL, and a 
subgroup analysis did not show any significant correlation between the 
SNP -509C>T or SNP 869T>C and OPLL subgroups. Stratification by 
gender demonstrated no significant effect. We conclude that promoter 
region (-509C>T) and exon 1 (869T>C) polymorphisms are not 
associated with OPLL in the Korean population.
Key words: Ossification; Posterior longitudinal ligament; 
Polymorphism; Transforming growth factor-β1
INTRODUCTION
Ossification of the posterior longitudinal ligament (OPLL) is characterized by ectopic 
ossification in the spinal ligaments. Abnormalities of bone metabolism play an important role 
in the occurrence of OPLL (Matsui et al., 1996). Both environmental and genetic factors are 
believed to contribute to individual susceptibility to OPLL (Saetia et al., 2011). Many research 
groups have investigated the associations between specific polymorphisms of bone metabo-
lism-related genes and genetic susceptibility to OPLL (Kamiya et al., 2001; Kawaguchi et 
al., 2003; Tsukahara et al., 2005; Kobashi et al., 2008; Wang et al., 2008; Liu et al., 2010). To 
date, however, highly relevant genes responsible for the occurrence of OPLL have not been 
precisely defined.
Transforming growth factor-β1 (TGF-β1) is one of the suggested candidate genes that 
contribute to genetic risk factors for OPLL occurrence for the following reasons. First, TGF-β1 
is an important regulator of bone metabolism, showing strong evidence of profound effects on 
the bone remodeling processes of bone resorption and formation (Kamiya et al., 2001; Kawa-
guchi et al., 2003, Janssens et al., 2005). Second, TGF-β1 is present in the ossified matrix and 
chondrocytes in cartilaginous areas adjacent to OPLL pathology (Kawaguchi et al., 2003; Ina-
masu et al., 2006). Third, TGF-β1 reportedly modulates bone development and fracture healing 
(Aufdemorte et al., 1992; Kawaguchi et al., 2003). Local administration of TGF-β1 has been 
reported to induce fracture healing or bone formation in animals (Schmidmaier et al., 2002). 
Finally, TGF-β1 knockout mice display reduced bone mass and elasticity (Geiser et al., 1998).
The TGF-β family consists of three isoforms - TGF-β1, TGF-β2, and TGF-β3 - with 
TGF-β1 being the most abundant in the bone matrix compared with levels in other tissues 
(Patil et al., 2011). Single nucleotide polymorphisms (SNPs) in the TGF-β1 gene have been 
detected in the coding region of the TGF-β1 gene and its promoter region. So far, only three 
studies have been conducted to determine potential association between OPLL occurrence and 
SNP 869T>C at exon 1 nucleotide position 29 in the coding region; the results, however, have 
been inconsistent and inconclusive (Kamiya et al., 2001; Kawaguchi et al., 2003; Horikoshi 
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et al., 2006). Polymorphism in the promoter region of TGF-β1 gene can also affect TGF-β1 
expression. The promoter SNP -509C>T reportedly contributes to osteoporosis by influencing 
bone mass (Yamada et al., 2001; Langdahl et al., 2003). However, no published studies have 
explored possible associations between polymorphisms in the TGF-β1 gene promoter region 
and susceptibility to OPLL. We therefore aimed to investigate whether promoter SNP -509C>T 
or exon 1 polymorphism at +869 (SNP 869T>C) are associated with genetic susceptibility to 
OPLL in a Korean population.
MATERIAL AND METHODS
Study population
The case-control population contained 298 adult unrelated Koreans selected from the 
same population living in Korea between 2008 and 2010. A total of 98 cervical OPLL patients 
(66 men, 32 women; mean age ± standard deviation, 52.9 ± 8.7 years) were recruited from 
Gangnam Severance Hospital, Yonsei Medical University (Seoul, South Korea). The presence 
of OPLL was determined from radiographic criteria based on computed tomography of the 
cervical spine. OPLL cases were classified into four subtypes: 1) continuous, involving a long 
lesion extending over several vertebral bodies; 2) segmental, involving one or several sepa-
rate lesions behind the vertebral bodies; 3) mixed, which is a combination of the continuous 
and segmental types; and 4) localized, involving a lesion mainly located posterior to a disc 
space. Compared with segmental and localized subtypes, the mixed and continuous subtypes 
of OPLL reportedly have the greatest risk of progression of the ossification area. Therefore, we 
categorized the cases into two groups, an OPLL segmental (segmental type plus localized type 
OPLL) and an OPLL continuous (continuous type plus mixed type OPLL), based on previous 
reports (Kawaguchi et al., 2001; Hori et al., 2006; Kudo et al., 2011).
Bone mineral density (BMD) was measured using dual-energy X-ray absorptiom-
etry of the lumbar spine and proximal femur. Standard laboratory examinations and thyroid 
hormone level measurements were performed routinely. Patients with disorders such as hy-
perthyroidism, primary hyperparathyroidism, or pituitary diseases and those receiving treat-
ments including oral contraceptives, hormones replacement therapy, glucocorticoids, calcium, 
or vitamin D that have potential to interfere with bone metabolism were excluded from the 
study. We also excluded the patients who had ankylosing spondylitis, osteoporosis, and diffuse 
idiopathic skeletal hyperostosis.
The control group comprised 200 healthy volunteers who visited the general health 
checkup division at Gangnam Severance Hospital, Yonsei Medical University. The mean age 
of the patients in the control group (115 men and 85 women) was 53.5 years (standard de-
viation, 9.5 years). Cervical spine computed tomography showed no evidence of OPLL in 
controls. The study was approved by the institutional review board of Gangnam Severance 
Hospital, and written informed consent was obtained from all participants.
Genotype analysis using polymerase chain reaction restriction fragment length 
polymorphism (PCR-RFLP) assay
Genotype analysis of the -509C>T polymorphism of the TGF-β1 gene was performed 
via PCR-RFLP assay. Genomic DNA was extracted from peripheral blood leukocytes by us-
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ing a G-DEX blood extraction kit (iNtRON Biotechnology, Inc., Seongnam, South Korea). 
The PCR primers were 5'-CAG TAA AGG AGA GCA ATT CTT AC-3' (forward) and 5'-GGT 
CAC CAG AGA AAG AGG AC-3' (reverse). Genomic DNA was amplified with PCR buffer 
containing 50 mL KCl, 10 mM Tris-HCl buffer, pH 8.3, 1.5 mM MgCl2, 0.2 mM of each de-
oxynucleotide triphosphate, 10 pM each primer, and 1 unit Taq polymerase (Takara, Madison, 
WI, USA). The PCR cycling conditions consisted of an initial denaturation step at 94°C for 5 
min followed by 35 cycles of 30 s at 94°C, 35 s at 58°C, 30 s at 72°C, and a final extension at 
72°C for 5 min. The PCR products were digested with DdeI (New England Biolabs, Ipswich, 
MA, USA) and analyzed with electrophoresis on 3% agarose gel.
Genotype analysis with TaqMan assays
TaqMan assay probes for SNP 869T>C were designed by Applied Biosystems (Foster 
City, CA, USA). The forward primer was 5'-CCC ACC ACAC CAG CCC TGT TC-3', and 
the reverse primer was 5'-TTC CGC TTC ACC AGC TCC ATG T-3'. The TaqMan probe for 
the detection of the T allele was FAM-TAG CAG CAG CAG CAG CAG CCG C-BHQ1, and 
the probe for the detection of the C allele was HEX-TAG CAG CAG CGG CAG CAG CCG-
BHQ1. The PCR program included an initial denaturation step at 95°C for 5 min followed 
by 45 cycles of denaturation at 95°C for 15 s and annealing/extension at 65°C for 20 s. PCR, 
endpoint fluorescence reading, and analysis of the data were performed with a 7500 Real Time 
PCR System (Applied Biosystems).
Statistical analysis
Genotype frequencies were compared between OPLL patients and controls using the 
chi-square test and the Fisher exact test when appropriate, and odds ratios and 95% confidence 
intervals were calculated to estimate the relative risk of OPLL conferred by each polymor-
phism. Association of SNPs with OPLL was analyzed with multivariate logistic regression 
adjusted for possible confounders, including age, gender, diabetes mellitus (DM), and BMD. 
Demographic data between groups were compared using the chi-square test for categorical 
variables such as gender and the prevalence of DM and using the Mann-Whitney test for 
quantitative variables such as age and BMD values. Statistical analyses were performed using 
SPSS for Windows 11.0 (SPSS Inc., Chicago, IL, USA) and the StatsDirect Statistical Soft-
ware (version 2.4.4, StatsDirect Ltd., Altrincham, UK). The level of statistical significance 
was set at P < 0.05.
RESULTS
The demographics of the patients and controls enrolled in this study are summarized 
in Table 1. No significant differences were found between patients and controls for mean age 
or gender distribution (see Table 1). No significant differences between the two groups were 
found with respect to BMD and the prevalence of DM (data not shown). Of the 98 OPLL 
patients, 64 belonged to the OPLL continuous group (continuous type, N = 30; plus mixed 
type, N = 34), and 34 belonged to the OPLL segmental group (segmental type, N = 17; plus 
localized type, N = 17; see Table 1).
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Values are reported as means ± SD. aCalculated by the Mann-Whitney test for continuous data and the chi-square 
test for categorical data.
Characteristics OPLL patients Controls Pa
Number (N) 98 200
Age [years, mean ± SD] 52.93 ± 8.66 53.47 ± 9.47 0.634
Male gender [N, %] 66 (67.3%) 115 (57.5%) 0.102
OPLL group
Continuous group (continuous + mixed type) 64 (65.3%)
Segmental group (segmental + localized) 34 (34.7%)
Table 1. Characteristics of patients with ossification of posterior longitudinal ligaments (OPLL) and controls.
The genotype frequencies of the TGF-β1 -509C>T and 869T>C polymorphisms 
among patients and controls are shown in Table 2. The genotype distributions of both poly-
morphisms among patients and controls were in Hardy-Weinberg equilibrium. The frequen-
cies of the CC, CT, and TT genotypes of SNP -509C>T were 27.0, 48.5, and 24.5% in controls 
and 25.5, 51.0, and 23.5% in patients, respectively. The frequencies of the TT, TC, and CC 
genotypes of SNP 869T>C were 26.5, 49.0, and 24.5% in controls and 25.5, 49.0, and 25.5% 
in patients, respectively. The frequencies of the -509T and 869C alleles were 0.523 and 0.524 
in controls and 0.490 and 0.500 in patients, respectively. No significant differences were found 
in the genotype frequencies of the TGF-β1 -509C>T and 869T>C polymorphisms between 
OPLL patients and controls (see Table 2). The combined genotype frequencies of TGF-β1 
-509C>T and 869T>C polymorphisms of patients and controls are also presented in Table 2. 
OPLL patients exhibited no significant differences in combined genotype frequencies relative 
to the controls. When OPLL patients were divided into the continuous and segmental groups, 
the association of TGF-β1 -509C>T and 869T>C polymorphisms with OPLL was not deter-
mined (Table 3). Genotype frequencies of the two polymorphisms were also estimated accord-
ing to gender, but stratification for gender yielded no significant results (Table 4).
AOR = adjusted odds ratio; 95%CI = 95% confidence interval; NA = not available; TGF-β1 = transforming growth 
factor-β1. P values were adjusted for age and gender.
 Controls (N = 200) OPLL patients (N = 98) AOR (95%CI) P
TGF-β1 -509
   CC 54 (27.0) 25 (25.5) 1.000 
   CT 97 (48.5) 50 (51.0) 1.122 (0.623-2.023) 0.702
   TT 49 (24.5) 23 (23.5) 1.082 (0.537-2.181) 0.826
   Dominant (CC vs CT+TT)   1.115 (0.640-1.943) 0.701
   Recessive (CC+CT vs TT)   1.026 (0.575-1.829) 0.931
TGF-β1 869
   TT 53 (26.5) 25 (25.5) 1.000 
   TC 98 (49.0) 48 (49.0) 1.020 (0.564-1.845) 0.948
   CC 49 (24.5) 25 (25.5) 1.173 (0.588-2.341) 0.650
   Dominant (TT vs TC+CC)   1.066 (0.612-1.859) 0.821
   Recessive (TT+TC vs CC)   1.137 (0.646-2.003) 0.656
TGF-β1 -509/869
   CC/TT 51 (25.5) 25 (25.5) 1.000 
   CC/CT 3 (1.0) 0 (0.0) NA 
   CC/CC 0 (0.0) 0 (0.0) NA 
   CT/TT 2 (1.0) 0 (0.0) NA 
   CT/CT 95 (47.5) 47 (48.0) 0.999 (0.549-1.818) 0.998
   CT/CC 0 (0.0) 3 (3.1) NA 
   TT/TT 0 (0.0) 0 (0.0) NA 
   TT/CT 0 (0.0) 1 (1.0) NA 
   TT/CC 49 (24.5) 22 (22.4) 0.986 (0.486-2.000) 0.968
Table 2. Genotypic distribution of the TGF-β1 polymorphism between ossification of posterior longitudinal 
ligament (OPLL) patients and controls.
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DISCUSSION
Abnormalities of bone metabolism play a role in the pathogenesis of OPLL (Furu-
kawa, 2006). OPLL appears to be a polygenic disease caused by environmental and/or genetic 
factors, including multiple susceptibility genes. Many genetic variants of modest effect are 
likely to contribute to the occurrence of OPLL by interacting with environmental factors such 
as mechanical stress (Furukawa, 2006). The TGF-β1 gene is considered the leading candidate 
for increasing individual susceptibility to OPLL because it is an important regulator of bone 
metabolism (Bonewald and Dallas, 1994; Kamiya et al., 2001; Kawaguchi et al., 2003; Jans-
sens et al., 2005). Bone matrix contains large amounts of latent TGF-β1, and active TGF-β1 
released from bone matrix during bone remodeling may have an important effect for increas-
ing bone resorption as well as bone formation (Bonewald and Mundy, 1990).
Among the polymorphisms found in the TGF-β1 gene, the 869T>C polymorphism in 
exon 1 is the only one studied thus far with regard to OPLL pathogenesis. The three studies 
that have investigated potential associations between SNP 869T>C and OPLL in Japanese 
populations have generated contradictory results (Kamiya et al., 2001; Kawaguchi et al., 2003; 
Horikoshi et al., 2006). For example, Kamiya et al. (2001) have reported that SNP 869T>C 
is a genetic determinant of predisposition for cervical OPLL, with the C allele of 869T>C 
representing a risk factor for genetic susceptibility to OPLL in a study that included 46 OPLL 
patients. Conversely, Kawaguchi et al. (2003) found no association between SNP 869T>C and 
the prevalence of OPLL in a larger patient sample (N = 369), but a stratified analysis based 
on the area of the ossified lesion identified a significant difference in genotypic distribution 
 Controls OPLL patients AOR (95%CI) P
Male N = 115 N = 66  
TGF-β1 -509
   CC 33 (28.7) 19 (28.8) 1.000 
   CT 59 (51.3) 36 (54.5) 1.051 (0.521-2.123) 0.889
   TT 23 (20.0) 11 (16.7) 0.822 (0.329-2.057) 0.676
   Dominant (CC vs CT+TT)   0.996 (0.509-1.948) 0.991
   Recessive (CC+CT vs TT)   0.824 (0.372-1.827) 0.634
TGF-β1 869
   TT 31 (27.0) 19 (28.8) 1.000 
   TC 61 (53.0) 33 (50.0) 0.847 (0.413-1.736) 0.649
   CC 23 (20.0) 14 (21.2) 0.994 (0.414-2.390) 0.990
   Dominant (TT vs TC+CC)   0.892 (0.453-1.756) 0.741
   Recessive (TT+TC vs CC)   1.118 (0.527-2.370) 0.772
Female N = 85 N = 32  
   TGF-β1 -509
   CC 21 (24.7)   6 (18.8) 1.000 
   CT 38 (44.7) 14 (43.8) 1.275 (0.426-3.819) 0.664
   TT 26 (30.6) 12 (37.5) 1.614 (0.518-5.031) 0.409
   Dominant (CC vs CT+TT)   1.419 (0.514-3.917) 0.500
   Recessive (CC+CT vs TT)   1.368 (0.583-3.208) 0.472
TGF-β1 869
   TT 22 (25.9)   6 (18.8) 1.000 
   TC 37 (43.5) 15 (46.9) 1.488 (0.503-4.406) 0.473
   CC 26 (30.6) 11 (34.4) 1.550 (0.493-4.875) 0.453
   Dominant (TT vs TC+CC)   1.509 (0.548-4.152) 0.426
   Recessive (TT+TC vs CC)   1.189 (0.502-2.820) 0.694
OPLL = ossification of posterior longitudinal ligament; AOR = adjusted odds ratio; 95%CI = 95% confidence 
interval; NA = not available; TGF-β1 = transforming growth factor-β1. P values were adjusted for age.
Table 4. Comparison of genotype frequencies for the TGF-β1 polymorphism according to gender.
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between patients with isolated cervical OPLL and those with OPLL along the entire spine. 
That is, patients with the C allele of 869T>C more frequently displayed OPLL in the cervical, 
thoracic, or lumbar spine, but the number of stratified subjects was relatively low (cervical, 
thoracic, or lumbar OPLL, N = 43; cervical OPLL alone, N = 51).
More recently, Horikoshi et al. (2006) have reported a large-scale case-control study 
(711 OPLL patients and 896 controls) that showed no definitive association between the 869T>C 
polymorphism and genetic susceptibility to OPLL. Our results are similar to those of these 
large-sample studies showing no association of 869T>C polymorphism with OPLL. Our study 
showed no significant difference in genotype frequencies of -509C>T and 869T>C polymor-
phisms between OPLL patients and controls. In addition, combined analysis of -509C>T and 
869T>C polymorphisms demonstrated that none was associated with susceptibility to OPLL.
Although defining the exact reasons for the discrepancies between these studies is dif-
ficult, possible contributors to the inconsistent outcomes may be differences in study design, 
sample size, environmental factors such as mechanical stress, levels of gene-environment in-
teractions, and genetic heterogeneity between populations. As examples, the frequencies of 
the -509T and 869C alleles among controls in our study were 0.523 and 0.524, respectively - 
values similar to those observed in healthy Japanese subjects (Kamiya et al., 2001; Kawaguchi 
et al., 2003) but higher than those in white subjects (McGuigan et al., 2007; Langdahl et al., 
2003, 2008). We showed that the genotype distributions of SNP-509C>T and SNP 869T>C 
in controls are indeed in Hardy-Weinberg equilibrium, suggesting that the genetic structure of 
our sample is comparable to that of other studies of TGF-β1 polymorphism in OPLL patients.
The -509C>T polymorphism in the promoter region of the TGF-β1 gene may alter 
TGF-β1 expression levels, although the molecular mechanism involved is unclear. The -509C>T 
polymorphism is located in a negative regulatory region of the TGF-β1 promoter (Kim et al., 
1989). Thus, -509C may selectively downregulate TGF-β1 expression, and increased TGF-ß1 
levels may be associated with -509T owing to the loss of negative regulation (Shah et al., 2006). 
The T allele of the -509C>T polymorphism has been associated with an increased risk of dis-
eases such as endometriosis, asthma, and breast cancer (Zhang et al., 2010; Huang et al., 2011; 
Lee et al., 2011). Furthermore, the associations of the -509C>T polymorphism with bone mass 
or osteoporosis have been investigated, both alone and in combination with 869T>C polymor-
phism, but have yielded inconsistent or contradictory results (Yamada et al., 2001; Langdahl et 
al., 2003, 2008). The T allele of the -509C>T polymorphism is associated with reduced bone 
mass in postmenopausal Japanese women (Yamada et al., 2001) and in white men (Langdahl et 
al., 2008), whereas the T allele is associated with increased BMD in Danish men and women 
(Langdahl et al., 2003). Another study has shown no association between the -509C>T poly-
morphism and BMD or bone loss in a British population (McGuigan et al., 2007).
Despite conflicting results in the association between the -509C>T polymorphism and 
bone mass, we hypothesized that -509C>T and 869T>C polymorphisms might trigger the 
development of OPLL by changing the levels of TGF-β1 production that affect bone forma-
tion. To test this hypothesis, we primarily examined possible associations between selected 
SNPs (-509C>T in the promoter and 869T>C in the exon 1) and the occurrence of OPLL in a 
Korean population via genotype analysis. We found no significant difference between OPLL 
patients and controls in terms of genotype distribution of SNP -509C>T and 869T>C. To our 
knowledge, this study is the first to assess whether the -509C>T polymorphism is associated 
with genetic susceptibility to OPLL, although the quality of our study is limited by the absence 
of assays measuring TGF-β1 levels in study participants.
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Patients with the mixed or continuous types of OPLL reportedly have the greatest 
risk of further progression of the ossification area compared with that associated with the 
segmental and localized subtypes (Kawaguchi et al., 2001; Hori et al., 2006; Kudo et al., 
2011). Because our sample sizes for each OPLL subtype (continuous subtype, N = 30; mixed 
subtype, N = 34; segmental subtype, N = 17; and localized subtype, N = 17) were relatively 
small, we stratified OPLL patients into just two groups: an OPLL continuous group (continu-
ous type plus mixed type) and an OPLL segmental group (segmental type plus localized type). 
Our stratified analysis based on OPLL grouping showed no significant association between 
TGF-β1 polymorphism and susceptibility to cervical OPLL. 
We emphasize that our study was a single-hospital-based study, and individuals were 
recruited from a center that traditionally treats more severe cases of OPLL. We focused on 
selected candidate genes only using a relatively small sample size of the Korean population 
without performing genome-wide association studies. These limitations may result in a mis-
understanding of the true impact contributed by individual risk factors, additional genetic 
factors, or ethnic differences.
Our data suggest that under both recessive and dominant genetic models, -509C>T 
and 869T>C polymorphisms did not correlate significantly with risk levels for OPLL in the 
Korean population examined. A subgroup analysis based on OPLL subtypes and gender and 
combination analysis of -509C>T and 869T>C polymorphisms also showed no significant as-
sociation of between TGF-β1 polymorphism and genetic susceptibility for OPLL. Large-scale 
population studies are required before a definitive conclusion can be drawn regarding signifi-
cant correlation between specific SNPs in the promoter and exon regions of the TGF-β1 gene 
and genetic susceptibility to OPLL.
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